Medtronic USA, Inc. Sustainability Profile
Medtronic USA, Inc., a leading global healthcare solutions company, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1949, Medtronic has established itself as a pioneer in the medical technology industry, focusing on innovative therapies and devices that improve patient outcomes. The company’s core business areas include cardiovascular, diabetes management, neurological, and surgical technologies. Medtronic is renowned for its advanced products, such as insulin pumps and cardiac devices, which are distinguished by their reliability and cutting-edge technology. With a strong market position, Medtronic has achieved numerous milestones, including the development of the first successful implantable pacemaker, solidifying its reputation as a trusted leader in medical innovation.
DitchCarbon Score
How does Medtronic USA, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medtronic USA, Inc.'s score of 50 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medtronic USA, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Medtronic plc, which may influence its climate commitments and emissions reporting. As part of its climate strategy, Medtronic plc has set various reduction initiatives that may cascade down to Medtronic USA, Inc. However, specific reduction targets or achievements for Medtronic USA, Inc. are not detailed in the available data. The company is involved in several initiatives, including those aligned with the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are sourced from Medtronic plc. While no absolute emissions figures are provided, Medtronic USA, Inc. is expected to adhere to the broader climate commitments established by its parent company, Medtronic plc. These commitments typically focus on reducing greenhouse gas emissions across all scopes, although specific targets for Scope 1, 2, or 3 emissions have not been disclosed for the subsidiary. In summary, while Medtronic USA, Inc. does not present specific emissions data or reduction targets, it is part of a larger corporate structure that is actively engaged in climate initiatives through its parent company, Medtronic plc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
How Carbon Intensive is Medtronic USA, Inc.'s Industry?
How Carbon Intensive is Medtronic USA, Inc.'s Location?
Medtronic USA, Inc.'s Scope 3 Categories Breakdown
Medtronic USA, Inc.'s Scope 3 emissions, which increased by 48% last year and increased by approximately 48% since 2021, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 55% of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 47% of Scope 3 emissions.
Top Scope 3 Categories
Medtronic USA, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medtronic USA, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
